-+ 0.00%
-+ 0.00%
-+ 0.00%

XTALPI SUBMITS U.S. FDA IND APPLICATION FOR KQTD-126, A POTENTIAL FIRST-IN-CLASS, GUT-RESTRICTED PAN-TRK INHIBITOR FOR CHRONIC INTESTINAL PAIN

Reuters·09/25/2026 00:30:03

Please log in to view news